New onset diabetes after renal transplantation: An experience from a developing country – India

Journal Title: International Archives of Integrated Medicine - Year 2017, Vol 4, Issue 7

Abstract

New onset diabetes after transplantation (NODAT) is one of the serious side effects of immunosuppressive medications used in renal transplant recipients. Diabetes in transplantation increases the risk of cardiovascular disease and has adverse outcome on graft and patient survival. The aim of this study was to evaluate the incidence of NODAT in renal transplant recipients, the risk factors for the development of NODAT and its effect on graft and patient survival. Total 210 patients underwent renal transplantation from Jan 2010 to June 2016. Mean follow-up period after renal transplantation was 38.14 + 20.12 months. NODAT was defined as two consecutive fasting blood glucose determinations above 126 mg/dL. Thirty five (16.66%) recipients developed NODAT, the duration of onset of NODAT was 4.22 months (range 1 month to 30 months) after transplantation. All of them required insulin treatment. NODAT disappeared in 3(8.57%) recipients with reduction in tacrolimus dose and conversion to everolimus. Cox-Regression analysis was done to estimate the hazard ratio at confidence interval to assess whether the age more than 50 years, deceased donor, induction therapy, graft dysfunction, graft rejection, tacrolimus toxicity, everolimus based immunosuppression, HCV and CMV infection were risk factors for the development of NODAT. Induction therapy and graft dysfunction had 2 fold increased risk of development of NODAT and tacrolimus toxicity had 4 fold increased risk of development of NODAT. Fungal infection (17.14% Vs 2.28%, P value 0.00) was significantly higher in NODAT group compared to recipients without NODAT. There was no significant difference in 6 months, 1, 2, 3 and 5 years patient survival or the death censored graft survival of recipients with NODAT compared to patients without NODAT.

Authors and Affiliations

Swarnalatha G, Karthik KR, Bharathi N, Raghavendra S, Siva Parvathi K, Deepti A, Gangadhar T

Keywords

Related Articles

A study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital

Introduction: Rising incidence of Diabetes mellitus, Systemic hypertension and Dyslipidemia, the well-known risk factor for cardiovascular disease is the leading cause for increased incidence of cardiovascular diseases1....

A prospective study of immediate maternal and neonatal effects of forceps and vacuum assisted deliveries

Introduction: The unaided human birth process is not perfect. All round the world 10% to20% of all pregnant women receive assistance with their delivery. Aim: This present study was to analyze and study the contribution...

A study to compare the efficacy of dexmedetomidine with esmolol on hemodynamic response during laparoscopic cholecystectomy

Introduction: Laparoscopic surgery is a routinely performed surgery and it is desirable to have stable intra-operative hemodynamic states by avoiding hypertension and tachycardia. Various drugs have been employed to atte...

Prevalence pattern precipitating factors and presenting features of congestive heart failure patients in GDMCH Dharmapuri

Introduction: Heart failure is the end stage of all diseases of the heart and is a major cause of morbidity and mortality. Since 1970s the treatment of CHF has been transformed, resulting in major benefit to patients. Th...

Comparison of I-gel and ProSeal laryngeal mask airway during volume controlled ventilation

Introduction: I-gel and the ProSeal laryngeal mask airway (PLMA) are two supra-glottic airway devices with gastric channel used for airway maintenance in anesthesia. This study was designed to evaluate the efficacy of I-...

Download PDF file
  • EP ID EP407628
  • DOI -
  • Views 164
  • Downloads 0

How To Cite

Swarnalatha G, Karthik KR, Bharathi N, Raghavendra S, Siva Parvathi K, Deepti A, Gangadhar T (2017). New onset diabetes after renal transplantation: An experience from a developing country – India. International Archives of Integrated Medicine, 4(7), 74-82. https://www.europub.co.uk/articles/-A-407628